Five Stocks That Have Investors Excited Today

Page 2 of 2

FDA Approval Boosts Shire 

Shire PLC (ADR) (NASDAQ:SHPG) shares have rallied by over 3% after the FDA approved the company’s product candidate, Xiidra 5%, the only treatment currently indicated for symptoms and signs of dry eye disease. Given that there are around 16 million people who have been diagnosed with dry eye disease in the United States alone, investors are expecting good commercial results from the drug. Shire plans to launch the drug in the third quarter of 2016. 49 funds that we monitor owned shares of Shire PLC (ADR) (NASDAQ:SHPG) at the end of March, up by nine funds from a quarter earlier.

Follow Shire Plc

Citigroup Cuts Its Losses

Citigroup Inc (NYSE:C) has become the latest firm to cut its exposure to the troubled Latin American country of Venezuela. According to the country’s President, Nicolas Maduro, Citigroup will soon terminate Venezuela’s foreign currency accounts due to the economic conditions in the nation. Venezuela has been struggling due to the low crude prices, which has slowed economic growth in the country. Citigroup shares are up by 2.4% today, mainly due to broader market strength. The number of top funds in our database with Citigroup Inc (NYSE:C) holdings on March 31 fell by five quarter-over-quarter to 101.

Follow Citigroup Inc (NYSE:C)

Disclosure: None

Page 2 of 2